journal article·2008-11Open access

Natural origin scaffolds with in situ pore forming capability for bone tissue engineering applications

Ana M. Martins, Marina I. Santos, Helena S. Azevedo, Patricia B. Malafaya, Rui L. Reis

Acta Biomaterialia· Volume 4· Issue 6

Abstract

This work describes the development of a biodegradable matrix, based on chitosan and starch, with the ability to form a porous structure in situ due to the attack by specific enzymes present in the human body (alpha-amylase and lysozyme). Scaffolds with three different compositions were developed: chitosan (C100) and chitosan/starch (CS80-20, CS60-40). Compressive test results showed that these materials exhibit very promising mechanical properties, namely a high modulus in both the dry and wet states. The compressive modulus in the dry state for C100 was 580+/-33MPa, CS80-20 (402+/-62MPa) and CS60-40 (337+/-78MPa). Degradation studies were performed using alpha-amylase and/or lysozyme at concentrations similar to those found in human serum, at 37 degrees C for up to 90 days. Scanning electron micrographs showed that enzymatic degradation caused a porous structure to be formed, indicating the potential of this methodology to obtain in situ forming scaffolds. In order to evaluate the biocompatibility of the scaffolds, extracts and direct contact tests were performed. Results with the MTT test showed that the extracts of the materials were clearly non-toxic to L929 fibroblast cells. Analysis of cell adhesion and morphology of seeded osteoblastic-like cells in direct contact tests showed that at day 7 the number of cells on CS80-20 and CS60-40 was noticeably higher than that on C100, which suggests that starch containing materials may promote cell adhesion and proliferation. This combination of properties seems to be a very promising approach to obtain scaffolds with gradual in vivo pore forming capability for bone tissue engineering applications.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Bone Tissue Engineering Materials · biodegradable polymer synthesis and properties · Electrospun Nanofibers in Biomedical Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (36)

Show source-provided references
1. The design of scaffolds for use in tissue engineering. Part 1. Traditional factors10.1089/107632701753337645 ↗
2. Bone tissue engineering: state of the art and future trends10.1002/mabi.200400026 ↗
3. State of the art and future directions of scaffold-based bone engineering from a biomaterials perspective10.1002/term.24 ↗
4. Application of chitosan-based polysaccharide biomaterials in cartilage tissue engineering: a review10.1016/S0142-9612(00)00126-5 ↗
5. Novel hydroxyapatite/chitosan bilayered scaffold for osteochondral tissue-engineering applications: scaffold design and its performance when seeded with goat bone marrow stromal cells10.1016/j.biomaterials.2006.07.034 ↗
6. Influence of the degree of acetylation on some biological properties of chitosan films10.1016/S0142-9612(00)00183-6 ↗
7. In vitro degradation rates of partially N-acetylated chitosans in human serum10.1016/S0008-6215(96)00332-1 ↗
8. In vitro and in vivo degradation of films of chitin and its deacetylated derivatives10.1016/S0142-9612(96)00167-6 ↗
9. Topical formulations and wound healing applications of chitosan10.1016/S0169-409X(01)00189-2 ↗
10. Osteogenesis enhanced by chitosan (poly-N-acetyl glucosaminoglycan) in vitro10.1902/jop.1996.67.11.1170 ↗
11. Stimulatory effect on bone formation exerted by a modified chitosan10.1016/0142-9612(94)90093-0 ↗
12. Lysozyme susceptibility of partially deacetylated chitin10.1016/0141-8130(90)90016-4 ↗
13. Lysozyme in human body fluids10.1016/0009-8981(74)90398-2 ↗
14. Degradation of partially N-acetylated chitosans with hen egg white and human lysozyme10.1016/0144-8617(96)00003-3 ↗
15. Understanding the enzymatic degradation of biodegradable polymers and strategies to control their degradation rate
16. Biochemical significance of exogenous chitins and chitosans in animals and patients
17. Cytocompatibility and response of osteoblastic-like cells to starch-based polymers: effect of several additives and processing conditions10.1016/S0142-9612(00)00377-X ↗
18. Novel starch-based scaffolds for bone tissue engineering: cytotoxicity, cell culture, and protein expression10.1089/107632704323061825 ↗
19. In vitro assessment of the enzymatic degradation of several starch based biomaterials10.1021/bm0300397 ↗
20. The biocompatibility of novel starch-based polymers and composites: in vitro studies10.1016/S0142-9612(01)00272-1 ↗
21. In vivo response to starch-based scaffolds designed for bone tissue engineering applications10.1002/jbm.a.30946 ↗
22. The degree of deacetylation of chitosan: advocating the first derivative UV-spectrophotometry method of determination10.1016/S0039-9140(97)00288-9 ↗
23. Production and characterization of chitosan fibers and 3-D fiber mesh scaffolds for tissue engineering applications10.1002/mabi.200300100 ↗
24. Evaluation of a new assay for pancreatic amylase: performance characteristics and estimation of reference intervals10.1016/S0009-9120(89)80007-4 ↗
25. Starch and starch based thermoplastics
26. In vivo and in vitro biodegradation of oxychitin–chitosan and oxypullulan–chitosan complexes10.1016/S0144-8617(01)00234-X ↗
27. Determination of lysozyme in serum, urine, cerebrospinal-fluid and feces by enzyme-immunoassay10.1016/0009-8981(84)90097-4 ↗
28. Human cartilage lysozyme10.1172/JCI107035 ↗
29. Tissue-engineered bone regeneration10.1038/79449 ↗
30. Proteins incorporated into biomimetically prepared calcium phosphate coatings modulate their mechanical strength and dissolution rate10.1016/S0142-9612(02)00252-1 ↗
31. BMP-2 liberated from biomimetic implant coatings induces and sustains direct ossification in an ectopic rat model10.1016/j.bone.2005.02.005 ↗
32. Incorporation of proteins and enzymes at different stages of the preparation of calcium phosphate coatings on a degradable substrate by a biomimetic methodology10.1016/j.msec.2005.01.007 ↗
33. From cytotoxicity to biocompatibility testing in vitro: cell adhesion molecule expression defines a new set of parameters10.1023/A:1018541419055 ↗
34. Platelet derived growth factor releasing chitosan sponge for periodontal bone regeneration10.1016/S0142-9612(99)00143-X ↗
35. Some background concepts
36. In vitro effects on MG63 osteoblast-like cells following contact with two roughness-differing fluorohydroxyapatite-coated titanium alloys10.1016/S0142-9612(02)00098-4 ↗